Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aldo Scarpa

Showing results (441-450 of 602) with videos related to

Pageof 61
Sort By:
International Journal of Cancer|October 7, 2017
Transcriptional variations in the wider peritumoral tissue environment of pancreatic cancerAndrea S Bauer, Petr V Nazarov, Nathalia A Giese, et al.
Cancer Biomarkers : Section a of Disease Markers|December 24, 2016
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutesAnna Caliò, Emilio Bria, Sara Pilotto, et al.
Expert Opinion on Therapeutic Targets|December 7, 2021
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profilesMichele Simbolo, Samantha Bersani, Caterina Vicentini, et al.
Annals of Surgery|May 6, 2024
Reappraising the Role of Intraoperative Neck Margin Revision in Post-Neoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-Institutional AnalysisGiuseppe Malleo, Gabriella Lionetto, Stefano Crippa, et al.
Oncotarget|January 23, 2016
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNAMarzia Del Re, Marcello Tiseo, Paola Bordi, et al.
Plos One|April 9, 2013
Somatic mutations in exocrine pancreatic tumors: association with patient survivalP Sivaramakrishna Rachakonda, Andrea S Bauer, Huaping Xie, et al.
American Journal of Cancer Research|December 19, 2014
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitorsClaudia Fiorini, Francesco Massari, Serena Pedron, et al.
Familial Cancer|January 25, 2022
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variantsAndrea Mafficini, Lodewijk A A Brosens, Maria L Piredda, et al.
Science Translational Medicine|March 15, 2023
Neutralization of NET-associated human ARG1 enhances cancer immunotherapyStefania Canè, Roza Maria Barouni, Marina Fabbi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological FactorsSara Pilotto, Isabella Sperduti, Silvia Novello, et al.
Pageof 61

Showing results (441-450 of 602) with videos related to

Sort By:
Pageof 61
International Journal of Cancer|October 7, 2017
Transcriptional variations in the wider peritumoral tissue environment of pancreatic cancerAndrea S Bauer, Petr V Nazarov, Nathalia A Giese, et al.
Cancer Biomarkers : Section a of Disease Markers|December 24, 2016
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutesAnna Caliò, Emilio Bria, Sara Pilotto, et al.
Expert Opinion on Therapeutic Targets|December 7, 2021
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profilesMichele Simbolo, Samantha Bersani, Caterina Vicentini, et al.
Annals of Surgery|May 6, 2024
Reappraising the Role of Intraoperative Neck Margin Revision in Post-Neoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-Institutional AnalysisGiuseppe Malleo, Gabriella Lionetto, Stefano Crippa, et al.
Oncotarget|January 23, 2016
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNAMarzia Del Re, Marcello Tiseo, Paola Bordi, et al.
Plos One|April 9, 2013
Somatic mutations in exocrine pancreatic tumors: association with patient survivalP Sivaramakrishna Rachakonda, Andrea S Bauer, Huaping Xie, et al.
American Journal of Cancer Research|December 19, 2014
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitorsClaudia Fiorini, Francesco Massari, Serena Pedron, et al.
Familial Cancer|January 25, 2022
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variantsAndrea Mafficini, Lodewijk A A Brosens, Maria L Piredda, et al.
Science Translational Medicine|March 15, 2023
Neutralization of NET-associated human ARG1 enhances cancer immunotherapyStefania Canè, Roza Maria Barouni, Marina Fabbi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological FactorsSara Pilotto, Isabella Sperduti, Silvia Novello, et al.
Pageof 61